Your browser doesn't support javascript.
loading
Replacement of the proximal aorta and aortic valve using a composite bileaflet prosthesis and gelatin-impregnated polyester graft (Carbo-Seal): early results in 143 patients.
Langley, S M; Rooney, S J; Dalrymple-Hay, M J; Spencer, J M; Lewis, M E; Pagano, D; Asif, M; Goddard, J R; Tsang, V T; Lamb, R K; Monro, J L; Livesey, S A; Bonser, R S.
Afiliación
  • Langley SM; Wessex Cardiothoracic Centre, Southampton General Hospital, Southampton, United Kingdom. StephenLangley@dial.pipex.com
J Thorac Cardiovasc Surg ; 118(6): 1014-20, 1999 Dec.
Article en En | MEDLINE | ID: mdl-10595972
ABSTRACT

OBJECTIVE:

We report the combined early results from two centers in the United Kingdom using a composite conduit consisting of a bileaflet mechanical valve incorporated into a gelatin-impregnated, ultra-low porosity, woven polyester graft (Carbo-Seal; Sulzer Carbomedics, Inc, Austin, Tex).

METHODS:

Between August 1992 and March 1997, 143 patients underwent aortic root replacement with the Carbo-Seal composite prosthesis. The indication for surgery was acute type A dissection in 31 (22%), chronic type A dissection in 9 (6%), ascending aortic aneurysm without dissection in 100 (70%), and false aneurysm of the ascending aorta in 3 (2%). Twenty-seven patients (19%) had undergone previous sternotomy, and 40 (28%) were seen as emergencies. Concomitant procedures were performed in 38 (27%), including 18 aortic arch or hemiarch replacements. Total follow-up is 270 patient-years. Follow-up is 100% complete.

RESULTS:

The early (30-day) mortality was 7% (10 patients). Permanent neurologic events occurred in 2%. At a mean follow-up of 23 months, 94% of survivors were in New York Heart Association functional class I. Freedom from reoperation was 97.2% +/- 1.6% (1 standard error [1 SE]) at 12 months and 95.7% +/- 2.2% at 48 months. Including early mortality, survival was 90.1% +/- 2.6% at 12 months and 83.1% +/- 3. 5% at 48 months.

CONCLUSIONS:

Aortic root replacement with use of the Carbo-Seal prosthesis can be undertaken with a relatively low early mortality and morbidity. A low reoperation rate and high intermediate-term survival can be expected, but continued follow-up is needed to determine the long-term efficacy of this prosthesis.
Asunto(s)
Buscar en Google
Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Aorta / Válvula Aórtica / Diseño de Prótesis / Prótesis Vascular / Prótesis Valvulares Cardíacas / Implantación de Prótesis de Válvulas Cardíacas / Implantación de Prótesis Vascular Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Thorac Cardiovasc Surg Año: 1999 Tipo del documento: Article País de afiliación: Reino Unido
Buscar en Google
Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Aorta / Válvula Aórtica / Diseño de Prótesis / Prótesis Vascular / Prótesis Valvulares Cardíacas / Implantación de Prótesis de Válvulas Cardíacas / Implantación de Prótesis Vascular Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Thorac Cardiovasc Surg Año: 1999 Tipo del documento: Article País de afiliación: Reino Unido